Insmed Inc (INSM)

May 09, 2025

Insmed (INSM) Receives Slight Price Target Adjustment by UBS | I - GuruFocus

May 09, 2025

May 09, 2025

UBS Maintains Buy Rating, Lowers Price Target for Insmed (INSM) - GuruFocus

May 09, 2025

May 09, 2025

Insmed's Q1 Loss Wider Than Expected, Sales Match Estimates - Yahoo Finance

May 09, 2025

May 09, 2025

$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today - Benzinga

May 09, 2025

May 09, 2025

Is Insmed Incorporated (INSM) the Best Cancer Stock to Invest in for Long-Term Gain? - Insider Monkey

May 09, 2025

May 09, 2025

Insmed (INSM) Receives Slight Price Target Adjustment by UBS | INSM Stock News - GuruFocus

May 09, 2025

May 09, 2025

RBC Trims Price Target on Insmed to $99 From $100, Keeps Outperform Rating - marketscreener.com

May 09, 2025

May 09, 2025

Insmed: Q1 Earnings Snapshot - Greenwich Time

May 09, 2025

May 09, 2025

Decoding Insmed Inc (INSM): A Strategic SWOT Insight - GuruFocus

May 09, 2025

May 08, 2025

Insmed’s Earnings Call: Strong Growth and Optimistic Outlook - TipRanks

May 08, 2025

May 08, 2025

Insmed Q1 2025 Earnings Call Transcript - MarketBeat

May 08, 2025

May 08, 2025

Transcript : Insmed Incorporated, Q1 2025 Earnings Call, May 08, 2025 - marketscreener.com

May 08, 2025

May 08, 2025

Earnings call transcript: Insmed Q1 2025 shows mixed results with slight EPS miss - Investing.com

May 08, 2025

May 08, 2025

Insmed (INSM) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 08, 2025

May 08, 2025

Insmed Q1 Net Loss Widens, Revenue Increases; 2025 Revenue Guidance Maintained - marketscreener.com

May 08, 2025

May 08, 2025

Insmed (INSM) Reports Q1 Revenue Surpassing Expectations and Awaits Key Approvals | INSM Stock News - GuruFocus

May 08, 2025

May 08, 2025

Insmed Q1 2025 slides: ARIKAYCE sales surge 23% as brensocatib launch approaches - Investing.com

May 08, 2025

May 08, 2025

Insmed earnings missed by $0.07, revenue topped estimates - Investing.com

May 08, 2025

May 08, 2025

Insmed Inc (INSM) Q1 2025 Earnings: Revenue Hits $92.8 Million, Surpassing Estimates - GuruFocus

May 08, 2025

May 08, 2025

Insmed Reports First-Quarter 2025 Financial Results and Provides Business Update | INSM Stock News - GuruFocus

May 08, 2025

May 08, 2025

Insmed Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 08, 2025

May 07, 2025

Dimensional Fund Advisors LP Sells 16,313 Shares of Insmed Incorporated (NASDAQ:INSM) - Defense World

May 07, 2025

May 04, 2025

Insmed Incorporated (INSM): Among the Large-Cap Stocks Insiders and Short Sellers Are Dumping Like Crazy - Insider Monkey

May 04, 2025

May 01, 2025

Earnings Preview: Insmed (INSM) Q1 Earnings Expected to Decline - Yahoo Finance

May 01, 2025

Apr 30, 2025

Insmed Incorporated (INSM): Among Billionaire George Soros’ Mid-Cap Stocks With Huge Upside Potential - Insider Monkey

Apr 30, 2025

Apr 29, 2025

Insmed To Present at the BofA Securities 2025 Health Care Conference - GuruFocus

Apr 29, 2025

Apr 29, 2025

Insmed To Present at the BofA Securities 2025 Health Care Conference | INSM Stock News - GuruFocus

Apr 29, 2025

Apr 28, 2025

Insmed Inc (INSM)’s Day in Review: Closing at 69.69, Up by 1.06 - DWinneX

Apr 28, 2025

Apr 28, 2025

Gaining Ground: Insmed Inc (INSM) Closes Lower at 72.00, Down -5.62 - DWinneX

Apr 28, 2025

Apr 27, 2025

Top Medical Stocks To Watch Now – April 25th - Defense World

Apr 27, 2025

Apr 25, 2025

Insmed Inc [INSM] moved down -2.60: Why It’s Important - dbtnews.com

Apr 25, 2025

Apr 25, 2025

Could investigational drug become first-in-class bronchiectasis therapy? - marketscreener.com

Apr 25, 2025

Apr 25, 2025

Insmed: Poised For Transformation Beyond ARIKAYCE (NASDAQ:INSM) - Seeking Alpha

Apr 25, 2025

Apr 25, 2025

Insmed Inc [INSM] stock for 479,177 USD was sold by Lewis William - knoxdaily.com

Apr 25, 2025

Apr 25, 2025

Insmed’s (INSM) Buy Rating Reiterated at HC Wainwright - Defense World

Apr 25, 2025

Apr 25, 2025

If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much TodayInsmed (NASDAQ:INSM) - Benzinga

Apr 25, 2025

Apr 25, 2025

Insmed Sees Unusually Large Options Volume (NASDAQ:INSM) - Defense World

Apr 25, 2025

Apr 24, 2025

Insmed Inc (INSM) Stock: Uncovering a 52-Week Range and Trading Volume - investchronicle.com

Apr 24, 2025

Apr 24, 2025

Insmed Calls In Convertible Notes, Proposes Share Conversion - Finimize

Apr 24, 2025

Apr 24, 2025

Insmed to redeem $569.5 million convertible notes due 2028 By Investing.com - Investing.com Canada

Apr 24, 2025

Apr 24, 2025

Insmed Inc (NASDAQ:INSM) Rises 5.71% In 2025; Is It Still Attractive At $70.85? - Marketing Sentinel

Apr 24, 2025

Apr 24, 2025

INSM’s price-to-sales ratio: A comparative analysis with its peers - uspostnews.com

Apr 24, 2025

Apr 24, 2025

Insmed to Redeem $569.5 Million of Convertible Senior Notes - marketscreener.com

Apr 24, 2025

Apr 24, 2025

Insmed Announces Redemption of all $569.5 Million of Remaining O - GuruFocus

Apr 24, 2025

Apr 24, 2025

Insmed Flexes Financial Muscle with $569M Early Note Redemption: What it Means for Investors - Stock Titan

Apr 24, 2025

Apr 23, 2025

Insmed Incorporated (INSM): Among Takeover Rumors Hedge Funds Are Buying - Yahoo Finance

Apr 23, 2025

Apr 23, 2025

Insmed (INSM) Reports Promising Phase 3 Results for Brensocatib - GuruFocus

Apr 23, 2025

Apr 23, 2025

New England Journal of Medicine Publishes Positive Results from Insmed's Pivotal Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis | INSM Stock News - GuruFocus

Apr 23, 2025

Apr 23, 2025

Insmed (INSM) Reports Promising Phase 3 Results for Brensocatib in Treating Bronchiectasis | INSM Stock News - GuruFocus

Apr 23, 2025

Apr 23, 2025

New England Journal of Medicine Publishes Positive Results from Insmed's Pivotal Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis - marketscreener.com

Apr 23, 2025